Two doses of 52-week nerandomilast, a phosphodiesterase 4B inhibitor, reduced FVC decline vs. placebo in patients with idiopathic pulmonary fibrosis, according to results published in the New England ...

CHAI, a fast-rising AI startup in Palo Alto, is rapidly emerging as the next unicorn with explosive revenue growth of 250%, surpassing industry leaders like Databricks (127%), SpaceX (139%), and ...

Discover why Novo Nordisk A/S' undervalued shares present a buying opportunity, with strong sales growth, profitability, and ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

Scientists have discovered a link between early-onset colon cancer and fatty liver disease. Suffered by one in four Americans, the disease often develops silently, with minimal or no symptoms.